| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.98B | 28.32B | 26.95B | 24.78B | 22.21B | 18.54B |
| Gross Profit | 27.45B | 27.01B | 6.82B | 6.15B | 4.06B | 1.33B |
| EBITDA | 8.48B | 6.78B | 6.81B | 6.63B | 4.94B | -2.93B |
| Net Income | 876.05M | 607.00M | 415.00M | 1.13B | -1.18B | -5.48B |
Balance Sheet | ||||||
| Total Assets | 64.47B | 63.65B | 65.76B | 65.80B | 68.30B | 77.49B |
| Cash, Cash Equivalents and Short-Term Investments | 11.52B | 11.51B | 12.80B | 11.06B | 11.80B | 16.05B |
| Total Debt | 36.27B | 35.81B | 38.36B | 39.94B | 42.33B | 50.11B |
| Total Liabilities | 44.63B | 44.42B | 46.78B | 46.51B | 49.28B | 57.28B |
| Stockholders Equity | 21.00B | 20.41B | 20.16B | 20.03B | 19.63B | 20.76B |
Cash Flow | ||||||
| Free Cash Flow | 731.60M | 4.03B | 5.88B | 4.91B | 4.66B | 1.07B |
| Operating Cash Flow | 1.96B | 6.16B | 8.10B | 5.93B | 5.39B | 2.72B |
| Investing Cash Flow | -1.21B | -3.27B | -1.74B | -1.18B | -863.00M | -658.00M |
| Financing Cash Flow | -689.01M | -4.67B | -4.45B | -5.73B | -8.93B | -277.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$203.29M | 1.62 | 2.95% | 8.10% | -0.75% | 35.42% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
48 Neutral | HK$456.44M | -0.26 | -7.56% | ― | -15.22% | 59.00% | |
45 Neutral | HK$28.88M | -0.30 | 4.61% | ― | 66.22% | 73.39% | |
44 Neutral | HK$92.34M | -1.05 | 42.21% | ― | ― | 63.51% | |
43 Neutral | HK$102.76M | -2.36 | -10.06% | ― | 1.24% | -96.15% | |
42 Neutral | HK$81.94M | -0.98 | -34.01% | ― | -0.31% | 34.83% |